SciELO - Scientific Electronic Library Online

 
vol.46 issue3Bilateral cryptococcal sacroiliitis: case report and literature reviewNeurosensory hearing loss in patients with Wegener's granulomatosis: a report of three cases and literature review author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista Brasileira de Reumatologia

Print version ISSN 0482-5004On-line version ISSN 1809-4570

Abstract

RANGEL, Leandro Vasconcellos et al. Topical therapy with pimecrolimus in refractory cutaneous lesion of systemic lupus erythematosus. Rev. Bras. Reumatol. [online]. 2006, vol.46, n.3, pp.230-233. ISSN 0482-5004.  http://dx.doi.org/10.1590/S0482-50042006000300013.

The rash of systemic lupus erythematosus (SLE) is usually treated with topical corticosteroids, but prolonged use causes adverse cutaneous side-effects. Pimecrolimus is a prototype of a class of topical immunosuppressive agents with great potential for the treatment of inflammatory skin diseases. Topical pimecrolimus therapy was applied to facial skin lesions in one case of SLE refractory to topical and systemic steroids. There was a marked regression of the skin lesions after pimecrolimus therapy. This treatment was well tolerated without side effects in this patient. Topical pimecrolimus seems to be a new tool for the management of refractory skin lesions in lupus erythematosus.

Keywords : pimecrolimus; systemic lupus erythematosus; inflammatory skin disease.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License